REFERENCES
- Yamamoto Y, Brodsky MH, Baker JC, Ames BN. Detection and characterization of lipid hydroperoxides at picomole levels by high-performance liquid chromatography. Anal Biochem 1987; 160: 7–13.
- Yamamoto Y, Niki E. Presence of cholesteryl ester hydroperoxide in human blood plasma. Biochem Biophys Res Commun 1989; 165: 988–993.
- Belkner J, Wiesner R, Kiihn H, Lankin VZ. The oxygenation of cholesterol esters by the reticulocyte lipoxygenase. FEBS Lett 1991; 279: 110–114.
- Mashima R, Onodera K, Yamamoto Y. Regioisomeric distribution of cholesteryl linoleate hydroperoxides and hydroxides in plasma from healthy humans provides evidence for free radical-mediated lipid peroxidation in vivo. J Lipid Res 2000; In press.
- Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts U. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 1990; 87: 9383–9387.
- Morrow JD, Frei B, Longmire AW et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. N Engl J Med 1995; 332: 1198–1203.
- Reilly MP, Delanty PN, Roy Let al. Increased formation of the isoprostanes IPF2-I and 8Epi-prostaglandin F2, in acute coronary angioplasty. Circulation 1997; 96: 3314–3320.
- Nourooz-Zadeh J, Millar CGM, Gopaul NK, Änggård EE. Increased levels of plasma 8Epi-PGF2 in patients with end stage renal failure. Redox Report 1997; 3: 207–211.
- Pratico D, Barry OP, Lawson JA et al. IPF2-I: an index of lipid peroxidation in humans. Proc Natl Acad Sci USA 1998; 95: 3449–3454.